Expression of NME1 is strongly associated with neuroblastoma patient outcomes, with elevated NME1 expression associated with reduced overall and event-free survival and with the strongest associations of any of the NME family member genes (Figure 1B and Supplementary Data 1). This evidence concerns the gene NME1 and neuroblastoma.